PMID- 27900411 OWN - NLM STAT- MEDLINE DCOM- 20170526 LR - 20211204 IS - 1420-908X (Electronic) IS - 1023-3830 (Linking) VI - 66 IP - 3 DP - 2017 Mar TI - Inflammatory protein response in CDKL5-Rett syndrome: evidence of a subclinical smouldering inflammation. PG - 269-280 LID - 10.1007/s00011-016-1014-2 [doi] AB - BACKGROUND: Mutations in the cyclin-dependent kinase-like 5 gene cause a clinical variant of Rett syndrome (CDKL5-RTT). A role for the acute-phase response (APR) is emerging in typical RTT caused by methyl-CpG-binding protein 2 gene mutations (MECP2-RTT). No information is, to date, available on the inflammatory protein response in CDKL5-RTT. We evaluated, for the first time, the APR protein response in CDKL5-RTT. METHODS: Protein patterns in albumin- and IgG-depleted plasma proteome from CDKL5-RTT patients were evaluated by two-dimensional gel electrophoresis/mass spectrometry. The resulting data were related to circulating cytokines and compared to healthy controls or MECP2-RTT patients. The effects of omega-3 polyunsaturated fatty acids (omega-3 PUFAs) were evaluated. RESULTS: CDKL5-RTT mutations resulted in a subclinical attenuated inflammation, specifically characterized by an overexpression of the complement component C3 and CD5 antigen-like, both strictly related to the inflammatory response. Cytokine dysregulation featuring a bulk increase of anti-inflammatory cytokines, predominantly IL-10, could explain the unchanged erythrocyte sedimentation rate and atypical features of inflammation in CDKL5-RTT. Omega-3 PUFAs were able to counterbalance the pro-inflammatory status. CONCLUSION: For the first time, we revealed a subclinical smouldering inflammation pattern in CDKL5-RTT consisting in the coexistence of an atypical APR coupled with a dysregulated cytokine response. FAU - Cortelazzo, Alessio AU - Cortelazzo A AD - Child Neuropsychiatry Unit, University Hospital Azienda Ospedaliera Universitaria Senese (AOUS), Viale M. Bracci 16, 53100, Siena, Italy. alessio.cortelazzo@biologo.onb.it. AD - Department of Medical Biotechnologies, University of Siena, Via A. Moro 2, 53100, Siena, Italy. alessio.cortelazzo@biologo.onb.it. AD - Clinical Pathology Laboratory Unit, University Hospital AOUS, Viale M. Bracci 16, 53100, Siena, Italy. alessio.cortelazzo@biologo.onb.it. FAU - de Felice, Claudio AU - de Felice C AD - Neonatal Intensive Care Unit, University Hospital AOUS, Viale M. Bracci 16, 53100, Siena, Italy. FAU - Leoncini, Silvia AU - Leoncini S AD - Child Neuropsychiatry Unit, University Hospital Azienda Ospedaliera Universitaria Senese (AOUS), Viale M. Bracci 16, 53100, Siena, Italy. AD - Department of Molecular and Developmental Medicine, University of Siena, Via A. Moro 6, 53100, Siena, Italy. FAU - Signorini, Cinzia AU - Signorini C AD - Department of Molecular and Developmental Medicine, University of Siena, Via A. Moro 6, 53100, Siena, Italy. FAU - Guerranti, Roberto AU - Guerranti R AD - Department of Medical Biotechnologies, University of Siena, Via A. Moro 2, 53100, Siena, Italy. AD - Clinical Pathology Laboratory Unit, University Hospital AOUS, Viale M. Bracci 16, 53100, Siena, Italy. FAU - Leoncini, Roberto AU - Leoncini R AD - Department of Medical Biotechnologies, University of Siena, Via A. Moro 2, 53100, Siena, Italy. AD - Clinical Pathology Laboratory Unit, University Hospital AOUS, Viale M. Bracci 16, 53100, Siena, Italy. FAU - Armini, Alessandro AU - Armini A AD - Department of Life Sciences, University of Siena, Via A. Moro 2, 53100, Siena, Italy. FAU - Bini, Luca AU - Bini L AD - Department of Life Sciences, University of Siena, Via A. Moro 2, 53100, Siena, Italy. FAU - Ciccoli, Lucia AU - Ciccoli L AD - Department of Molecular and Developmental Medicine, University of Siena, Via A. Moro 6, 53100, Siena, Italy. FAU - Hayek, Joussef AU - Hayek J AD - Child Neuropsychiatry Unit, University Hospital Azienda Ospedaliera Universitaria Senese (AOUS), Viale M. Bracci 16, 53100, Siena, Italy. LA - eng PT - Journal Article DEP - 20161129 PL - Switzerland TA - Inflamm Res JT - Inflammation research : official journal of the European Histamine Research Society ... [et al.] JID - 9508160 RN - 0 (Blood Proteins) RN - 0 (Cytokines) RN - 0 (Fatty Acids, Omega-3) RN - 0 (MECP2 protein, human) RN - 0 (Methyl-CpG-Binding Protein 2) RN - EC 2.7.11.1 (Protein Serine-Threonine Kinases) RN - EC 2.7.11.22 (CDKL5 protein, human) RN - CDKL5 deficiency disorder SB - IM MH - Acute-Phase Reaction/genetics/*immunology/metabolism MH - Adolescent MH - Blood Proteins/immunology/metabolism MH - Child MH - Child, Preschool MH - Cytokines/blood/*immunology MH - Dietary Supplements MH - Epileptic Syndromes MH - Fatty Acids, Omega-3/pharmacology MH - Female MH - Humans MH - Infant MH - Methyl-CpG-Binding Protein 2/genetics MH - Protein Serine-Threonine Kinases/genetics MH - Rett Syndrome/genetics/*immunology/metabolism MH - Spasms, Infantile/genetics/*immunology/metabolism OTO - NOTNLM OT - Acute-phase proteins OT - Cyclin-dependent kinase-like 5 OT - Cytokines OT - Polyunsaturated fatty acids OT - Rett syndrome OT - Subclinical inflammation EDAT- 2016/12/03 06:00 MHDA- 2017/05/27 06:00 CRDT- 2016/12/01 06:00 PHST- 2016/07/27 00:00 [received] PHST- 2016/11/23 00:00 [accepted] PHST- 2016/11/06 00:00 [revised] PHST- 2016/12/03 06:00 [pubmed] PHST- 2017/05/27 06:00 [medline] PHST- 2016/12/01 06:00 [entrez] AID - 10.1007/s00011-016-1014-2 [pii] AID - 10.1007/s00011-016-1014-2 [doi] PST - ppublish SO - Inflamm Res. 2017 Mar;66(3):269-280. doi: 10.1007/s00011-016-1014-2. Epub 2016 Nov 29.